4.3 Article

Percutaneous Neuromodulation of the Brachial Plexus and Sciatic Nerve for the Treatment of Acute Pain Following Surgery: Secondary Outcomes From a Multicenter, Randomized, Controlled Pilot Study

Journal

NEUROMODULATION
Volume -, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1111/ner.13492

Keywords

Ambulatory surgery; percutaneous peripheral nerve stimulation; postoperative analgesia; regional anesthesia; ultrasound-guided regional anesthesia

Funding

  1. U.S. Army Medical Research Acquisition Activity, Fort Detrick, MD
  2. Assistant Secretary of Defense for Health Affairs [W81XWH-18-2-0003, W81XWH-18-2-0007, W81XWH-18-2-0008, W81XWH-18-2-0009]
  3. National Center for Complementary and Integrative Health (NCCIH) [U24 AT009769]
  4. Office of Behavioral and Social Sciences Research (OBSSR) [U24 AT009769]

Ask authors/readers for more resources

The study shows that ambulatory percutaneous PNS for brachial plexus and sciatic nerve leads significantly reduces postoperative pain and opioid consumption. This treatment approach demonstrates effectiveness in acute pain management following orthopedic surgery, without systemic side effects.
Objectives We recently reported that percutaneous peripheral nerve stimulation (PNS or neuromodulation) decreased pain and opioid consumption within the first two weeks following ambulatory surgery. However, the anatomic lead locations were combined for the analysis, and benefits for each location remain unknown. We therefore now report the effects of percutaneous PNS for brachial plexus and sciatic nerve leads separately. Materials and Methods Before surgery, leads were implanted percutaneously to target the brachial plexus (N = 21) for rotator cuff repair or sciatic nerve (N = 40) for foot/ankle surgery, followed by a single injection of local anesthetic. Postoperatively, subjects were randomized in a double masked fashion to 14 days of electrical stimulation (N = 30) or sham/placebo (N = 31) using an external pulse generator. The primary outcome of interest was opioid consumption and pain scores evaluated jointly. Thus, stimulation was deemed effective if superior on either outcome and at least noninferior on the other. Results For brachial plexus leads, during the first seven postoperative days pain measured with the numeric rating scale in participants given active stimulation was a median [interquartile range ] of 0.8 [0.5, 1.6] versus 3.2 [2.7, 3.5] in patients given sham (p < 0.001). For this same group, opioid consumption in participants given active stimulation was 10 mg [5, 20] versus 71 mg [35, 125] in patients given sham (p = 0.043). For sciatic nerve leads, pain scores for the active treatment group were 0.7 [0, 1.4] versus 2.8 [1.6, 4.6] in patients given sham (p < 0.001). During this same period, participants given active stimulation consumed 5 mg [0, 30] of opioids versus 40 mg [20, 105] in patients given sham (p = 0.004). Treatment effects did not differ statistically between the two locations. Conclusions Ambulatory percutaneous PNS of both the brachial plexus and sciatic nerve is an effective treatment for acute pain free of systemic side-effects following painful orthopedic surgery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available